CXCL8 and autoimmune disease: Furthermore, capsules around SBIs contain inflammatory cells (Figure 3a, b) that are predominantly Th1/Th17 cells, releasing high amounts of IL-6, IL-8, IL-17 and IFN-γ as well as defective regulatory T-cells, which possibly may result in the development of inflammatory/autoimmune diseases [54].